Skip to main content
. 2018 Jul 4;75(4):521–529. doi: 10.1007/s00244-018-0544-8

Table 3.

Objective neurological findings: cumulative data

Parameters Total (n = 137) Male (n = 70) Female (n = 67) P value
Memory impairment 22 (16.1) 11 (15.7) 11 (16.4) 1.00
Frontal release sign 4 (2.9) 0 (0.0) 4 (6.0) 0.06
Cranial nerves
 I 38 (27.7) 22 (31.4) 16 (23.9) 0.35
 II 12 (8.8) 4 (5.7) 8 (11.9) 0.24
 III 1 (0.7) 0 (0.0) 1 (1.5) 0.45
 IV 0 (0.0) 0 0 NA
 V 0 (0.0) 0 0 NA
 VI 0 (0.0) 0 0 NA
 VII 5 (3.6) 3 (4.3) 2 (3.0) 1.00
 VIII 69 (50.4) 32 (45.7) 37 (55.2) 0.31
 IX 0 (0.0) 0 0 NA
 X 0 (0.0) 0 0 NA
 XI 0 (0.0) 0 0 NA
 XII 0 (0.0) 0 0 NA
Motor dysfunction
 Hemiparesis 14 (10.2) 7 (10.0) 7 (10.4) 1.00
 Neuropathy 3 (2.2) 3 (4.3) 0 (0.0) 0.23
 Tremor 1 (0.7) 1 (1.4) 0 (0.0) 1.00
 Parkinsonism 1 (0.7) 0 (0.0) 1 (1.5) 0.49
Sensory dysfunction
 Bilateral distal limbs 39 (28.5) 20 (28.6) 19 (28.4) 1.00
 Laterality (hemi) 11 (8.0) 3 (4.3) 8 (11.9) 0.12
 Headache 2 (1.5) 1 (1.4) 1 (1.5) 1.00
Cerebellar dysfunction 9 (6.6) 5 (7.1) 4 (6.0) 1.00
Gait disturbance due to
 Sensory abnormalities 14 (10.2) 10 (14.3) 4 (6.0) 0.16
 Hemiparesis (stroke) 8 (5.8) 3 (4.3) 5 (7.5) 0.49
 Orthopedic problems 6 (4.4) 0 (0.0) 6 (9.0) 0.01*
 Parkinsonism 2 (1.5) 0 (0.0) 2 (3.0) 0.24
No neurological abnormalities 37 (27.0) 20 (28.6) 17 (25.4) 0.70

NA not analyzed

*P < 0.05, categorical variables are shown as numbers (percentages)